HomeInsightsStock Comparison

Laurus Labs Ltd vs Supriya Lifescience Ltd Stock Comparison

Laurus Labs Ltd vs Supriya Lifescience Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Laurus Labs Ltd is ₹ 848.05 as of 01 Aug 15:30.
  • The P/E Ratio of Laurus Labs Ltd changed from 13.5 on March 2020 to 92.4 on March 2025 . This represents a CAGR of 37.79% over 6 yearsThe P/E Ratio of Supriya Lifescience Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Laurus Labs Ltd changed from ₹ 3449 crore on March 2020 to ₹ 33099 crore on March 2025 . This represents a CAGR of 45.78% over 6 yearsThe Market Cap of Supriya Lifescience Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Laurus Labs Ltd for the Jun '25 is ₹ 1580 crore as compare to the Mar '25 revenue of ₹ 1778 crore. This represent the decline of -11.18% The revenue of Supriya Lifescience Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Laurus Labs Ltd for the Jun '25 is ₹ 392.56 crore as compare to the Mar '25 ebitda of ₹ 479.17 crore. This represent the decline of -18.08% The ebitda of Supriya Lifescience Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Laurus Labs Ltd changed from ₹ 28.4 crore to ₹ 161.08 crore over 9 quarters. This represents a CAGR of 116.27% The net profit of Supriya Lifescience Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Laurus Labs Ltd changed from 10.13 % on March 2020 to 17.01 % on March 2025 . This represents a CAGR of 9.02% over 6 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 19.96 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Laurus Labs Ltd

  • Laurus Labs Limited was originally incorporated as 'Laurus Labs Private Limited' on September 19, 2005 at Hyderabad, Andhra Pradesh, India as a private limited company.
  • The company was subsequently converted into a public limited company and its name was changed to Laurus Labs Limited on February 12, 2007.
  • Subsequently the name of the company was changed to Aptuit Laurus Limited consequent to the strategic partnership entered into by the company with Aptuit Singapore on July 19, 2007.
  • Thereafter the company was converted into a private limited company and its name was changed to Aptuit Laurus Private Limited on July 24, 2007.
  • Subsequently, company was converted into a public limited company and the name of the company was changed to Laurus Labs Limited on August 16, 2016. Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology.

About Supriya Lifescience Ltd

  • Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
  • The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
  • Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
  • It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
  • The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

Laurus Labs Ltd News Hub

News

Volumes spurt at Laurus Labs Ltd counter

Poonawalla Fincorp Ltd, Kajaria Ceramics Ltd, Aadhar Housing Finance Ltd, SBI Life Insuran...

Read more

28 Jul 2025 11:00

News

Laurus Labs Ltd rises for third consecutive session

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 893....

Read more

28 Jul 2025 13:05

News

Laurus Labs climbs on robust Q1 earnings

Gross margin improved to 59.4% in Q1 June 2025, up from 55.1% in Q1 June 2024. Profit befo...

Read more

28 Jul 2025 14:46

News

Laurus Labs to announce Quarterly Result

Laurus Labs will hold a meeting of the Board of Directors of the Company on 25 July 2025. ...

Read more

10 Jul 2025 10:29

News

Laurus Labs invests Rs 39.99 cr in Laurus Bio

Laurus Labs has invested Rs 39.99 crore and acquired 15,414 Series A2 Compulsorily Convert...

Read more

26 Jun 2025 13:24

News

Laurus Labs Ltd spurts 1.63%, up for five straight sessions

Laurus Labs Ltd rose for a fifth straight session today. The stock is quoting at Rs 680.9,...

Read more

26 Jun 2025 13:00

Supriya Lifescience Ltd News Hub

News

Board of Supriya Lifesciences recommends final dividend

Supriya Lifesciences announced that the Board of Directors of the Company at its meeting h...

Read more

27 May 2025 19:48

News

Supriya Lifesciences to announce Quarterly Result

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 27 Ma...

Read more

21 May 2025 19:30

News

Board of Supriya Lifescience appoints company secretary and compliance officer

The Board of Supriya Lifescience at its meeting held on 10 March 2025 has approved the app...

Read more

10 Mar 2025 15:37

News

Supriya Lifesciences to hold board meeting

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 10 Ma...

Read more

06 Mar 2025 09:34

News

Supriya Lifesciences declare Quarterly Result

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 24 Ja...

Read more

17 Jan 2025 11:05

News

Supriya Lifescience inaugurates new API production block at Lote Parshuram site

Supriya Lifescience  inaugurated its new multipurpose Active Pharmaceutical Ingredients (A...

Read more

17 Dec 2024 16:57

SWOT Analysis Of Laurus Labs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Supriya Lifescience Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Laurus Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Supriya Lifescience Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Laurus Labs Ltd and Supriya Lifescience Ltd

Which company has a larger market capitalization, Laurus Labs Ltd or Supriya Lifescience Ltd?

Market cap of Laurus Labs Ltd is 45,779 Cr while Market cap of Supriya Lifescience Ltd is 5,287 Cr

What are the key factors driving the stock performance of Laurus Labs Ltd and Supriya Lifescience Ltd?

The stock performance of Laurus Labs Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Laurus Labs Ltd and Supriya Lifescience Ltd?

As of August 2, 2025, the Laurus Labs Ltd stock price is INR ₹848.05. On the other hand, Supriya Lifescience Ltd stock price is INR ₹656.95.

How do dividend payouts of Laurus Labs Ltd and Supriya Lifescience Ltd compare?

To compare the dividend payouts of Laurus Labs Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions